Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2008;111:1380-1387
© 2008 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Denny, L.
Right arrow Articles by Myer, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denny, L.
Right arrow Articles by Myer, L.
Related Collections
Right arrow Cytology/colposcopy
Right arrow Epidemiology/public health
Right arrow Gynecologic oncology
Right arrow Infectious disease

ORIGINAL RESEARCH

Human Papillomavirus Infection and Cervical Disease in Human Immunodeficiency Virus-1–Infected Women

Lynette Denny, FCOG (SA), PhD1, Rosalind Boa, MB CHB1, Anna-Lise Williamson, PhD2,3, Bruce Allan, MSc2, Diane Hardie, PhD2,3, Ress Stan, MB CHB, FCP (SA)4 and Landon Myer, PhD5

From the 1Department Obstetrics and Gynaecology, 2University of Cape Town, and The Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; 3National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa; 4Department of Medicine, University of Cape Town, Cape Town, South Africa; 5Infectious Diseases Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa; and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York.

OBJECTIVE: To report on the natural history of high-risk human papillomavirus (HPV) infection and cervical disease in human immunodeficiency virus (HIV)-1–infected women living in Cape Town, South Africa.

METHODS: This was a prospective study of 400 untreated, HIV-1–infected women who underwent high-risk HPV DNA testing, cytology, colposcopy, histology, and CD4 count testing every 6 months for 36 months. Human immunodeficiency virus viral loads and HPV type distribution were determined at entry and after 18 months.

RESULTS: Sixty-eight percent of the women were high-risk HPV DNA positive at entry, 35% had a cytologic diagnosis of low-grade squamous intraepithelial lesion (LSIL), and 13% had high-grade squamous intraepithelial lesion (HSIL). There were no cancers. Abnormal cytology and high-risk HPV positivity were strongly correlated with low CD4 counts and high HIV viral loads. The most prevalent types of HPV were HPV-16, -52, -53, -35, and -18. Incident high-risk HPV infection occurred in 22%, and of those infected with high-risk HPV, 94% of infections persisted over an 18-month period, and 6% cleared their infections. Cytologic progression to SIL from normal/atypical squamous cells of undetermined significance cytology occurred in 17% of cases, but only 4% of cases of LSIL progressed to HSIL.

CONCLUSION: There is a high level of high-risk HPV infection in HIV-1 infected women, but progression to HSIL over 36 months occurred in the minority of cases. We recommend an initial colposcopy for an abnormal test, and if no high-grade lesion is identified, triennial screening would be appropriate. Human papillomavirus type 16 was the commonest, and HPV-18 was the fifth commonest, suggesting that vaccination against these two types would have a significant effect.

LEVEL OF EVIDENCE: II




This article has been cited by other articles:


Home page
JWatch GeneralHome page
Cervical Disease Is Common Among HPV-Positive Women with HIV
Journal Watch (General), June 26, 2008; 2008(626): 6 - 6.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American College of Obstetricians and Gynecologists.